Last 12 months
Inside the activity.
2 purchase rows · 30 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 4 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 2 | 8 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 6 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2021 Filed Jun 14, 2021 22:53 UTC |
Fattori Ruth ADirector
|
GrantClass A Common Stock | 150,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-080929 · tm2119549-20_4seq1.xml · nonDerivative · entry 1 Fattori Ruth A · CIK 0001306826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 12 equal quarterly installments beginning on June 30, 2021, which vesting will be delayed to the extent the Issuer (as defined below) has not filed a Form S-8 registering such shares by the applicable vesting date, subject to Ms. Fattori's continued service through the applicable vesting date. F2 · price: In connection with the closing of the transactions contemplated by the Business Combination Agreement, dated as of February 18, 2021, by and among HighCape Capital Acquisition Corp. ("HighCape"), Tenet Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of HighCape ("Merger Sub"), and Quantum-Si Incorporated, a Delaware corporation ("Quantum-Si"), pursuant to which Merger Sub merged with and into Quantum-Si (the "Merger"), with Quantum-Si surviving as a wholly-owned subsidiary of HighCape (which changed its name to "Quantum-Si Incorporated", the "Issuer"), these shares were received in exchange for 188,089 RSUs of Quantum-Si. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 22:53 UTC |
DEKKERS MARIJN EDirector
|
GrantClass A Common Stock | 150,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-080928 · tm2119549-19_4seq1.xml · nonDerivative · entry 2 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 F3 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 12 equal quarterly installments beginning on June 30, 2021, which vesting will be delayed to the extent the Issuer has not filed a Form S-8 registering such shares by the applicable vesting date, subject to Dr. Dekkers's continued service through the applicable vesting date. F4 · price: Received in connection with the Merger in exchange for 188,089 RSUs of Qunatum-Si. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 22:53 UTC |
DEKKERS MARIJN EDirector
|
GrantClass A Common Stock | 500,000 | $10.00 | $5,000,000.00 |
DisclosureSEC source: 0001104659-21-080928 · tm2119549-19_4seq1.xml · nonDerivative · entry 1 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Novalis Lifesciences Investments I, LP Disclosed balance after: 500,000 F1 · shares: In connection with the closing of the transactions contemplated by the Business Combination Agreement, dated as of February 18, 2021, by and among HighCape Capital Acquisition Corp. ("HighCape"), Tenet Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of HighCape ("Merger Sub"), and Quantum-Si Incorporated, a Delaware corporation ("Quantum-Si"), pursuant to which Merger Sub merged with and into Quantum-Si (the "Merger"), with Quantum-Si surviving as a wholly-owned subsidiary of HighCape (which changed its name to "Quantum-Si Incorporated", the "Issuer"), Novalis Lifesciences Investments I, LP ("Novalis") purchased 500,000 shares of Class A common stock from the Issuer, at a price of $10.00 per share, in a private placement immediately prior to the closing of the Merger. F2 · ownership.nature: Dr. Dekkers has sole voting and investment control over the shares held by Novalis. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 22:52 UTC |
LaPointe ChristianGeneral Counsel & Corp. Secr.
|
GrantClass A Common Stock | 50,000 | $10.00 | $500,000.00 |
DisclosureSEC source: 0001104659-21-080927 · tm2119549-18_4seq1.xml · nonDerivative · entry 2 LaPointe Christian · CIK 0001856912 · General Counsel & Corp. Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,346 F3 · shares: Dr. LaPointe purchased 50,000 shares of Class A common stock from the Issuer, at a price of $10.00 per share, in a private placement immediately prior to the closing of the Merger. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 22:52 UTC |
LaPointe ChristianGeneral Counsel & Corp. Secr.
|
GrantClass A Common Stock | 170,346 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-080927 · tm2119549-18_4seq1.xml · nonDerivative · entry 1 LaPointe Christian · CIK 0001856912 · General Counsel & Corp. Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,346 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% on January 7, 2022, with the remainder vesting in 12 equal quarterly installments thereafter, subject to Dr. LaPointe's continued service through the applicable vesting date. F2 · price: In connection with the closing of the transactions contemplated by the Business Combination Agreement, dated as of February 18, 2021, by and among HighCape Capital Acquisition Corp. ("HighCape"), Tenet Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of HighCape ("Merger Sub"), and Quantum-Si Incorporated, a Delaware corporation ("Quantum-Si"), pursuant to which Merger Sub merged with and into Quantum-Si (the "Merger"), with Quantum-Si surviving as a wholly-owned subsidiary of HighCape (which changed its name to "Quantum-Si Incorporated", the "Issuer"), these shares were received in exchange for 213,600 RSUs of Quantum-Si. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 22:51 UTC |
MCKENNA MICHAEL PPresident and COO
|
GrantClass A Common Stock | 79,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-080923 · tm2119549-16_4seq1.xml · nonDerivative · entry 2 MCKENNA MICHAEL P · CIK 0001207108 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 877,250 F2 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% on March 12, 2022, with the remainder vesting in 12 equal quarterly installments thereafter, subject to Dr. McKenna's continued service through the applicable vesting date. F3 · price: Received in connection with the Merger in exchange for 100,000 RSUs of Quantum-Si. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 22:51 UTC |
MCKENNA MICHAEL PPresident and COO
|
GrantClass A Common Stock | 797,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-080923 · tm2119549-16_4seq1.xml · nonDerivative · entry 1 MCKENNA MICHAEL P · CIK 0001207108 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 797,500 F1 · price: In connection with the closing of the transactions contemplated by the Business Combination Agreement, dated as of February 18, 2021, by and among HighCape Capital Acquisition Corp. ("HighCape"), Tenet Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of HighCape ("Merger Sub"), and Quantum-Si Incorporated, a Delaware corporation ("Quantum-Si"), pursuant to which Merger Sub merged with and into Quantum-Si (the "Merger"), with Quantum-Si surviving as a wholly-owned subsidiary of HighCape (which changed its name to "Quantum-Si Incorporated", the "Issuer"), these shares were received in exchange for 1,000,000 shares of Quantum-Si common stock. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 22:49 UTC |
Drayton ClaudiaChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 191,399 | Not disclosed Strike: $9.46 | Not disclosed |
DisclosureSEC source: 0001104659-21-080921 · tm2119549-14_4seq1.xml · derivative · entry 2 Drayton Claudia · CIK 0001629827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,399 Underlying: Class A Common Stock · 191,399 shares Expires 2031-04-21 F4 · price: Received in connection with the Merger in exchange for a stock option to acquire 240,000 shares of Quantum-Si common stock for $7.54 per share. F3 · derivative.exercise_date: The shares underlying this option vest as to 25% on June 30, 2022, with the remainder vesting in 36 equal monthly installments thereafter, subject to Ms. Drayton's continued service through the applicable vesting date. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 22:49 UTC |
Drayton ClaudiaChief Financial Officer
|
GrantClass A Common Stock | 95,700 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-080921 · tm2119549-14_4seq1.xml · nonDerivative · entry 1 Drayton Claudia · CIK 0001629827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,700 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% on June 30, 2022, with the remainder vesting in 12 equal quarterly installments thereafter, subject to Ms. Drayton's continued service through the applicable vesting date. F2 · price: In connection with the closing of the transactions contemplated by the Business Combination Agreement, dated as of February 18, 2021, by and among HighCape Capital Acquisition Corp. ("HighCape"), Tenet Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of HighCape ("Merger Sub"), and Quantum-Si Incorporated, a Delaware corporation ("Quantum-Si"), pursuant to which Merger Sub merged with and into Quantum-Si (the "Merger"), with Quantum-Si surviving as a wholly-owned subsidiary of HighCape (which changed its name to "Quantum-Si Incorporated", the "Issuer"), these shares were received in exchange for 120,000 RSUs of Quantum-Si. Read SEC document |
| June 10, 2021 Filed Jun 15, 2021 21:27 UTC |
RAKIN KEVINDirector
|
GrantClass A Common Stock | 1,901,000 | $10.00 | $19,010,000.00 |
DisclosureSEC source: 0001104659-21-081583 · tm2119549-25_4seq1.xml · nonDerivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,901,000 F1 · shares: Consists of (i) 100,000 shares of the Company's Class A common stock held by Mr. Rakin and the Kevin L. Rakin Irrevocable Trust, (ii) 601,000 shares of the Company's Class A common stock held by HighCape Partners QSI II Invest, L.P, (iii) 24,527 shares of the Company's Class A common stock held by HighCape Partners II, L.P. and F2 · shares: (iv) 1,175,473 shares of the Company's Class A common stock held by HighCape Partners QP II, L.P. Mr. Rakin and Matt Zuga are the managing members of HighCape Capital II GP, LLC, which is the general partner of HighCape Partners II GP, L.P., which is the general partner of each of HighCape Partners QSI II Invest, L.P, HighCape Partners II, L.P. and HighCape Partners QP II, L.P., and as a result each may be deemed to share voting and investment discretion with respect to the common stock held by such entities. Mr. Rakin disclaims any beneficial ownership of the securities to be held by HighCape Partners QSI II Invest, L.P, HighCape Partners II, L.P. and HighCape Partners QP II, L.P. other than to the extent of any pecuniary interest he may have therein, directly or indirectly. F3 · shares: In connection with the closing of the transactions (the "Business Combination") contemplated by the Business Combination Agreement, dated as of February 18, 2021, by and among HighCape Capital Acquisition Corp. ("HighCape"), Tenet Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of HighCape ("Merger Sub"), and Quantum-Si Incorporated, a Delaware corporation ("Quantum-Si"), pursuant to which Merger Sub merged with and into Quantum-Si (the "Merger"), with Quantum-Si surviving as a wholly-owned subsidiary of HighCape (which changed its name to "Quantum-Si Incorporated", the "Issuer"), these shares were purchased, at a price of $10.00 per share, in a private placement immediately prior to the closing of the Merger. F1 · ownership.nature: Consists of (i) 100,000 shares of the Company's Class A common stock held by Mr. Rakin and the Kevin L. Rakin Irrevocable Trust, (ii) 601,000 shares of the Company's Class A common stock held by HighCape Partners QSI II Invest, L.P, (iii) 24,527 shares of the Company's Class A common stock held by HighCape Partners II, L.P. and Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.